BTIG analyst Ryan Zimmerman raised the firm’s price target on Stryker (SYK) to $412 from $410 and keeps a Buy rating on the shares. Stryker continues to deliver robust above market top-line growth consistently year-in and year-out, expanding operating margins in the face of tariffs, and improving leverage and free cash flow, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker: Sustained Double-Digit Growth and Operating Leverage Support Buy Rating Despite 2026 Tariff Headwinds
- Closing Bell Movers: Apple reverse post-earnings gains; Sandisk rallies
- Stryker sees FY26 adjusted EPS $14.90-$15.10, consensus $14.94
- Stryker reports Q4 adjusted EPS $4.47, consensus $4.40
- Stryker options imply 3.7% move in share price post-earnings